“We need to be having more conversations about menopause”
Women and Parkinson's
Author: Heather KennedyPublished: 28 November 2019
Prep: Cook: Serves:
Heather Kennedy, a writer, advocate and mother who
lives near San Francisco, US, lays bare the physical and emotional challenges
of managing the onset of menopause with Parkinson’s – from the night sweats and
a decreasing interest in sex to the sense of “turning inwards”
I was first diagnosed with Parkinson’s in 2011, at the age
As I approach the menopause, I’ve noticed changes in
myself. First of all, I have a lower libido. I just want nothing to do with sex
at the moment, which is unusual! Secondly, I find myself turning inwards. I
find myself getting quieter and retreating into my shell, which means I’m
further isolating myself inside this condition. I implore women with
Parkinson’s to make sure you connect with other women at this time in your life
– talk to one another, come together. We need to be having way more
conversations about menopause, and particularly about how menopause affects
women with Parkinson’s. This getting smaller, this sense of receding as a
person – it’s the opposite of what people with Parkinson’s should be doing.
I never questioned how the condition might affect me as a woman until I started experiencing unexplainable off times in the days leading up to my periods. I was complaining to my girlfriends, when one friend schooled me. She explained that during periods the efficacy of women’s medication decreases. No one had ever told me that! I then started to notice the pattern like clockwork. Since being perimenopausal, though, my periods have become far more unpredictable in heaviness and length.
“That just doesn’t
I have started to sweat through my sheets every night. I
was unsure if it was a result of my medication or because of the menopause, and
that’s the problem – none of these changes happen inside a vacuum. It’s not like
I can pinpoint that ‘this thing is caused by hormonal changes’ and ‘this part
is caused by medication’. All of these things melt into one so it’s hard to
tell what’s happening to my body. Most of the time the doctors can’t tell.
I tried to ask my doctor if the night sweats could be
because of the menopause. He insisted I was too young – even though at 49 I
don’t think I am – and just told me to see my gynaecologist. Though he is
usually patient, I was a little surprised at how he brushed me off.
There are other ways my progressing Parkinson’s affects me as a woman, urinary incontinence being one. Sometimes I’m too stubborn to wear a pad – I’d rather pee in my pants than wear a big honking mattress between my legs! That just doesn’t feel sexy! I suppose getting old in itself makes you feel a little less juicy but combine that with the symptoms associated with this condition – and the onset of menopause – and it’s fair to say I feel a little more insecure these days. Dating men has made that harder too. As soon as I say I have Parkinson’s, I never hear from them again.
One thing I’ve noticed in the Parkinson’s community is how women are openly shamed for experiencing impulse control disorders to do with sex (hyper compulsion being a side effect from our Parkinson’s medication) but when it’s men you hear that phrase: ‘Boys will be boys’. I just think that dynamic is so wrong. I experienced hyper compulsion but in my case it was with cleaning and shopping. I got very intense about cleaning out the closet – my daughter said, ‘Mum, you’ve been cleaning the closet for three days’. These drugs are powerful, and they cause major changes in us. We need more warning about that.
Need to know: Heather Kennedy– whose pen name is Kathleen Kiddo – is a writer, speaker and Parkinson’s advocate who was diagnosed with Parkinson’s in 2011 at the age of 41. She lives with her two children in California, US. Heather is publishing two new books, one on grief and the other a collection of short stories, in the coming year.
Parkinson’s and menopause: the facts
Common side-effects of menopause can often be confused with Parkinson’s symptoms
Currently there isn’t enough research on women with Parkinson’s for doctors to know whether to recommend the use of hormone replacement therapy (HRT)
A study involving a group of women with Parkinson’s aged 35 to 59 revealed that many were anxious about their bodies and sexual image – unfortunately such concerns are rarely addressed by doctors
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Each week, we’ll be sharing the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
Scientists ‘revive’ foetal implant treatment for Parkinson’s
Foetal cells are injected into a man's brain to 'cure' his Parkinson's
3 weeks ago
Plant-based compounds could treat chronic pain in Parkinson’s, study finds
A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”
Could playing table tennis help reduce Parkinson’s symptoms?
Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…
‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s
Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…